OS Therapies Inc (OSTX)
AMEXHealth CareBiotechnologySnapshot 2026-09-04
$1.88+3.30%
Close 2026-09-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · OSTX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Operating Expenses & Income | |||||
| R&D Expenses | 26.0 | 16.4 | 2.8 | 3.2 | — |
| Operating Income | (37.6) | (28.7) | (6.8) | (4.3) | — |
| Earnings from Continuing Operations | |||||
| Interest Expense | — | — | 2.1 | — | — |
| Interest & Investment Income | 0.0 | 0.0 | — | 0.0 | — |
| Other Non-Operating Income / Expenses | (1.8) | (0.0) | (2.1) | (3.4) | — |
| Net Income | |||||
| Net Income | (39.4) | (28.8) | (8.9) | (7.8) | — |
| Per Share | |||||
| Basic EPS | — | (0.98) | (0.88) | (1.46) | — |
| Diluted EPS | (0.90) | (0.98) | (0.88) | (1.46) | — |
| Basic Weighted Avg Shares | — | — | 12.4 | 5.4 | — |
| Diluted Weighted Avg Shares | 43.9 | 29.3 | — | — | — |
| Supplemental | |||||
| EBITDA | — | (28.3) | — | — | — |
| EBIT | (37.6) | (28.7) | (6.8) | (4.3) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.